Literature DB >> 8442331

Superficial necrolytic dermatitis (necrolytic migratory erythema) in dogs.

T L Gross1, M D Song, P J Havel, P J Ihrke.   

Abstract

Twenty-two dogs with superficial necrolytic dermatitis were evaluated prospectively, twenty-one of which had characteristic crusting lesions of the paw pads. Histologically, epidermal lesions included parakeratosis and laminar intracellular edema. The plasma amino acid concentrations of eight dogs were markedly depressed. Nine dogs had terminal diabetes mellitus. These clinical and morphologic findings were strikingly similar to those of necrolytic migratory erythema in human beings, the most common cause of which is hyperglucagonemia due to islet cell tumor of the pancreas. No pancreatic tumors were found in these dogs; plasma glucagon concentrations in the five dogs tested were normal. The serum alkaline phosphatase concentrations were elevated in all dogs. Severe vacuolar hepatopathy, suggesting metabolically or hormonally induced hepatic dysfunction, was found in 21 dogs at necropsy or by biopsy; one dog had ultrasonographic abnormalities of the liver. Histopathologically, severe vacuolar alteration resulted in parenchymal collapse and nodular regeneration, which grossly mimicked cirrhosis. Although the definitive metabolic stimulus was not discovered for the cutaneous and hepatic lesions, the similarity of the cutaneous and biochemical features of canine superficial necrolytic dermatitis to human necrolytic migratory erythema warrants further investigation into possible underlying pancreatic hormonal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442331     DOI: 10.1177/030098589303000110

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  6 in total

1.  Superficial necrolytic dermatitis (hepatocutaneous syndrome) in a dog.

Authors:  B J McEwen
Journal:  Can Vet J       Date:  1994-01       Impact factor: 1.008

2.  A case of necrolytic migratory erythema managed for 24 months with intravenous amino acid and lipid infusions.

Authors:  Jonathan F Bach; Seth A Glasser
Journal:  Can Vet J       Date:  2013-09       Impact factor: 1.008

3.  Long-Term Management with Adipose Tissue-Derived Mesenchymal Stem Cells and Conventional Treatment in a Dog with Hepatocutaneous Syndrome.

Authors:  A Nam; S-M Han; D-M Go; D-Y Kim; K-W Seo; H-Y Youn
Journal:  J Vet Intern Med       Date:  2017-08-07       Impact factor: 3.333

4.  Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.

Authors:  John P Loftus; Adam J Miller; Sharon A Center; Jeanine Peters-Kennedy; Michael Astor
Journal:  J Vet Intern Med       Date:  2021-11-25       Impact factor: 3.333

5.  Successful Long-Term Management of Canine Superficial Necrolytic Dermatitis With Amino Acid Infusions and Nutritionally Balanced Home-Made Diet Modification.

Authors:  Jared A Jaffey; Robert C Backus; Megan Sprinkle; Catherine Ruggiero; Sylvia H Ferguson; Kate Shumway
Journal:  Front Vet Sci       Date:  2020-01-31

6.  Clinical features and amino acid profiles of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.

Authors:  John P Loftus; Sharon A Center; Michael Astor; Adam J Miller; Jeanine Peters-Kennedy
Journal:  J Vet Intern Med       Date:  2021-09-02       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.